{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:29:27Z","timestamp":1789669767244,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13918-2","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T08:10:31Z","timestamp":1742631031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-term outcomes of salvage high-dose-rate brachytherapy for localized recurrence of prostate cancer following definitive radiation therapy: a retrospective analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Kenta","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Kamitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiro","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Tokiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Miyaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Tamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Katsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"key":"13918_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"13918_CR2","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s10147-024-02517-z","volume":"29","author":"K Nakamura","year":"2024","unstructured":"Nakamura K, Nihei K, Saito Y, Shikama N, Noda SE, Hara R, et al. A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer. Int J Clin Oncol. 2024;29:847\u201352. https:\/\/doi.org\/10.1007\/s10147-024-02517-z.","journal-title":"Int J Clin Oncol"},{"key":"13918_CR3","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/s0360-3016(03)00632-1","volume":"57","author":"DA Kuban","year":"2003","unstructured":"Kuban DA, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, et al. Long-term multi-institutional analysis of stage T1\u2013T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys. 2003;57:915\u201328. https:\/\/doi.org\/10.1016\/s0360-3016(03)00632-1.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"13918_CR4","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/cncr.20093","volume":"100","author":"D Khuntia","year":"2004","unstructured":"Khuntia D, Reddy CA, Mahadevan A, Klein EA, Kupelian PA. Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1\u2013T3 prostate carcinoma in the prostate-specific antigen era: what should we expect? Cancer. 2004;100:1283\u201392. https:\/\/doi.org\/10.1002\/cncr.20093.","journal-title":"Cancer"},{"key":"13918_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/srao.2003.50015","volume":"13","author":"DC Beyer","year":"2003","unstructured":"Beyer DC. Brachytherapy for recurrent prostate cancer after radiation therapy. Semin Radiat Oncol. 2003;13:158\u201365. https:\/\/doi.org\/10.1053\/srao.2003.50015.","journal-title":"Semin Radiat Oncol"},{"key":"13918_CR6","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","volume":"65","author":"M Roach 3rd","year":"2006","unstructured":"Roach M 3rd, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006;65:965\u201374. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.04.029.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"13918_CR7","doi-asserted-by":"publisher","unstructured":"Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R et al. NCCN Guidelines\u00ae Insights: Prostate cancer, version 1.2023. J Natl Compr Canc Netw. 2022;20:1288\u201398. https:\/\/doi.org\/10.6004\/jnccn.2022.0063.","DOI":"10.6004\/jnccn.2022.0063"},{"key":"13918_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41391-018-0106-1","volume":"22","author":"JL Mohler","year":"2019","unstructured":"Mohler JL, Halabi S, Ryan ST, Al-Daghmin A, Sokoloff MH, Steinberg GD, et al. Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series. Prostate Cancer Prostatic Dis. 2019;22:309\u201316. https:\/\/doi.org\/10.1038\/s41391-018-0106-1.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"13918_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.euo.2018.12.011","volume":"3","author":"G Ingrosso","year":"2020","unstructured":"Ingrosso G, Becherini C, Lancia A, Caini S, Ost P, Francolini G, et al. Nonsurgical salvage local therapies for Radiorecurrent prostate cancer: A systematic review and meta-analysis. Eur Urol Oncol. 2020;3:183\u201397. https:\/\/doi.org\/10.1016\/j.euo.2018.12.011.","journal-title":"Eur Urol Oncol"},{"key":"13918_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.euo.2023.01.009","volume":"6","author":"D Pasquier","year":"2023","unstructured":"Pasquier D, Lacornerie T, Supiot S, Pommier P, Quivrin M, Simon JM, et al. The safety and efficacy of salvage stereotactic radiation therapy in patients with intraprostatic tumor recurrence after previous external radiation therapy: Phase 1 results from the GETUG-AFU 31 study. Eur Urol Oncol. 2023;6:399\u2013405. https:\/\/doi.org\/10.1016\/j.euo.2023.01.009.","journal-title":"Eur Urol Oncol"},{"key":"13918_CR11","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1200\/JCO.23.01391","volume":"42","author":"C Ekanger","year":"2024","unstructured":"Ekanger C, Helle SI, Reis\u00e6ter L, Hysing LB, Kv\u00e5le R, Honor\u00e9 A, et al. Salvage reirradiation for locally recurrent prostate cancer: results from a prospective study with 7.2 years of follow-up. J Clin Oncol. 2024;42:1934\u201342. https:\/\/doi.org\/10.1200\/JCO.23.01391.","journal-title":"J Clin Oncol."},{"key":"13918_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.brachy.2013.11.005","volume":"13","author":"Y Yamada","year":"2014","unstructured":"Yamada Y, Kollmeier MA, Pei X, Kan CC, Cohen GN, Donat SM, et al. A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy. Brachytherapy. 2014;13:111\u20136. https:\/\/doi.org\/10.1016\/j.brachy.2013.11.005.","journal-title":"Brachytherapy"},{"key":"13918_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.radonc.2016.04.032","volume":"119","author":"P Wojcieszek","year":"2016","unstructured":"Wojcieszek P, Szlag M, G\u0142owacki G, Cholewka A, Gawkowska-Suwi\u0144ska M, Kellas-\u015al\u0119czka S, et al. Salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after primary radiotherapy failure. Radiother Oncol. 2016;119:405\u201310. https:\/\/doi.org\/10.1016\/j.radonc.2016.04.032.","journal-title":"Radiother Oncol"},{"key":"13918_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.prro.2021.04.007","volume":"11","author":"SY Wu","year":"2021","unstructured":"Wu SY, Wong AC, Shinohara K, Roach M 3rd, Cunha JAM, Valdes G, et al. Salvage high-dose-rate brachytherapy for recurrent prostate cancer after definitive radiation. Pract Radiat Oncol. 2021;11:515\u201326. https:\/\/doi.org\/10.1016\/j.prro.2021.04.007.","journal-title":"Pract Radiat Oncol"},{"key":"13918_CR15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00066-017-1157-2","volume":"193","author":"G Chatzikonstantinou","year":"2017","unstructured":"Chatzikonstantinou G, Zamboglou N, R\u00f6del C, Zoga E, Strouthos I, Butt SA, et al. High-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy: A systematic review. Strahlenther Onkol. 2017;193:683\u201391. https:\/\/doi.org\/10.1007\/s00066-017-1157-2.","journal-title":"Strahlenther Onkol"},{"key":"13918_CR16","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ijrobp.2018.06.039","volume":"102","author":"J Murgic","year":"2018","unstructured":"Murgic J, Morton G, Loblaw A, D\u2019Alimonte L, Ravi A, Wronski M, et al. Focal salvage high dose-rate brachytherapy for locally recurrent prostate cancer after primary radiation therapy failure: results from a prospective clinical trial. Int J Radiat Oncol Biol Phys. 2018;102:561\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.06.039.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"13918_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.radonc.2019.09.006","volume":"141","author":"I Henr\u00edquez L\u00f3pez","year":"2019","unstructured":"Henr\u00edquez L\u00f3pez I, Gonz\u00e1lez-San Segundo C, Vegas JO, Gutierrez C, Hervas A, Cabeza Rodriguez M\u00c1, et al. Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy. Radiother Oncol. 2019;141:156\u201363. https:\/\/doi.org\/10.1016\/j.radonc.2019.09.006.","journal-title":"Radiother Oncol"},{"key":"13918_CR18","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/cncr.22940","volume":"110","author":"GW Allen","year":"2007","unstructured":"Allen GW, Howard AR, Jarrard DF, Ritter MA. Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option. Cancer. 2007;110:1405\u201316. https:\/\/doi.org\/10.1002\/cncr.22940.","journal-title":"Cancer"},{"key":"13918_CR19","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ijrobp.2021.10.138","volume":"112","author":"J Crook","year":"2022","unstructured":"Crook J, Rodgers JP, Pisansky TM, Trabulsi EJ, Amin MB, Bice W, et al. Salvage low-dose-rate prostate brachytherapy: clinical outcomes of a Phase 2 trial for local recurrence after external beam radiation therapy (NRG oncology\/RTOG 0526). Int J Radiat Oncol Biol Phys. 2022;112:1115\u201322. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.10.138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"13918_CR20","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/iju.12373","volume":"21","author":"H Sasaki","year":"2014","unstructured":"Sasaki H, Kido M, Miki K, Kuruma H, Takahashi H, Aoki M, et al. Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy. Int J Urol. 2014;21:572\u20137. https:\/\/doi.org\/10.1111\/iju.12373.","journal-title":"Int J Urol"},{"key":"13918_CR21","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1464-410X.2007.07045.x","volume":"100","author":"M Ismail","year":"2007","unstructured":"Ismail M, Ahmed S, Kastner C, Davies J. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. BJU Int. 2007;100:760\u20134. https:\/\/doi.org\/10.1111\/j.1464-410X.2007.07045.x.","journal-title":"BJU Int"},{"key":"13918_CR22","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1002\/cncr.26631","volume":"118","author":"H Uddin Ahmed","year":"2012","unstructured":"Uddin Ahmed H, Cathcart P, Chalasani V, Williams A, McCartan N, Freeman A, et al. Whole-gland salvage high-intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy. Cancer. 2012;118:3071\u20138. https:\/\/doi.org\/10.1002\/cncr.26631.","journal-title":"Cancer"},{"key":"13918_CR23","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.urolonc.2013.12.014","volume":"32","author":"H Tran","year":"2014","unstructured":"Tran H, Kwok J, Pickles T, Tyldesley S, Black PC. Underutilization of local salvage therapy after radiation therapy for prostate cancer. Urol Oncol. 2014;32:701\u20136. https:\/\/doi.org\/10.1016\/j.urolonc.2013.12.014.","journal-title":"Urol Oncol"},{"key":"13918_CR24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1464-410X.2012.11774.x","volume":"111","author":"H Ahmadi","year":"2013","unstructured":"Ahmadi H, Daneshmand S. Androgen deprivation therapy: evidence-based management of side effects. BJU Int. 2013;111:543\u20138. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11774.x.","journal-title":"BJU Int"},{"key":"13918_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/jama.2013.8638","volume":"310","author":"F Lapi","year":"2013","unstructured":"Lapi F, Azoulay L, Niazi MT, Yin H, Benayoun S, Suissa S. Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer. JAMA. 2013;310:289\u201396. https:\/\/doi.org\/10.1001\/jama.2013.8638.","journal-title":"JAMA"},{"key":"13918_CR26","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.6004\/jnccn.2012.0115","volume":"10","author":"M Gazta\u00f1aga","year":"2012","unstructured":"Gazta\u00f1aga M, Crook J. Androgen deprivation therapy: minimizing exposure and mitigating side effects. J Natl Compr Canc Netw. 2012;10:1088\u201395. https:\/\/doi.org\/10.6004\/jnccn.2012.0115.","journal-title":"J Natl Compr Canc Netw"},{"key":"13918_CR27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/iju.14880","volume":"29","author":"N Kamitani","year":"2022","unstructured":"Kamitani N, Miyaji Y, Tamada T, Yoden E, Kawata Y, Watanabe K, et al. Feasibility of magnetic resonance imaging-ultrasound guided high-dose-rate brachytherapy for localized prostate cancer: preliminary results from a prospective study. Int J Urol. 2022;29:725\u201332. https:\/\/doi.org\/10.1111\/iju.14880.","journal-title":"Int J Urol"},{"key":"13918_CR28","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1016\/j.ejca.2015.07.019","volume":"51","author":"RF Wolff","year":"2015","unstructured":"Wolff RF, Ryder S, Bossi A, Briganti A, Crook J, Henry A, et al. A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer. Eur J Cancer. 2015;51:2345\u201367. https:\/\/doi.org\/10.1016\/j.ejca.2015.07.019.","journal-title":"Eur J Cancer"},{"key":"13918_CR29","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ijrobp.2013.01.027","volume":"86","author":"CP Chen","year":"2013","unstructured":"Chen CP, Weinberg V, Shinohara K, Roach M 3rd, Nash M, Gottschalk A, et al. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys. 2013;86:324\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.01.027.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"13918_CR30","unstructured":"NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae) prostate cancer. version 4.2023. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf."},{"key":"13918_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.971344","volume":"12","author":"C M\u00e9nard","year":"2022","unstructured":"M\u00e9nard C, Navarro-Domenech I, Liu ZA, Joseph L, Barkati M, Berlin A, et al. MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer. Front Oncol. 2022;12: 971344. https:\/\/doi.org\/10.3389\/fonc.2022.971344.","journal-title":"Front Oncol"},{"key":"13918_CR32","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1007\/s11604-024-01621-4","volume":"42","author":"N Kamitani","year":"2024","unstructured":"Kamitani N, Watanabe K, Ikeda N, Kawata Y, Tokiya R, Hayashi T, et al. Long-term outcomes of high-dose-rate brachytherapy and external beam radiotherapy without hormone therapy for high-risk localized prostate cancer. Jpn J Radiol. 2024;42:1322\u20139. https:\/\/doi.org\/10.1007\/s11604-024-01621-4.","journal-title":"Jpn J Radiol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13918-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T08:10:35Z","timestamp":1742631035000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13918-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13918"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13918-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"assertion":[{"value":"21 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Kawasaki Medical School (approval number: 5329\u201303, 577 Matsushima, Kurashiki City, Okayama 701\u20130192, Japan) and Okayama University (approval number: 2501\u2013024, 2\u20135-1 Shikatacho, Kita-ku, Okayama City, Okayama 700\u20138558, Japan). This study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all patients prior to treatment, and they were provided the option to opt out of the study via a notification on the institution\u2019s website.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"524"}}